U.S. President Joe Biden meets with House Speaker Kevin McCarthy (R-CA) in the Oval Office of the White House on May 22, 2023 in Washington, DC.
Drew Angerer | Getty Images News | Getty Images
This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You can subscribe here.
The only story to be made of yesterday’s market moves is that, well, there wasn’t one. Markets are still in reactive mode, not a sustained rally.
What you need to know today
- BlackRock’s bond chief Rick Rieder said the U.S. economy is in much better shape than most people think. Challenging recession fears, Rieder said, “it’s pretty unusual [or] almost impossible when you have an unemployment rate of 3.4%.”
- Apple has entered a multibillion-dollar with U.S. chipmaker Broadcom to design and build 5G radio frequency components in the U.S. The move reflects Apple’s investment in the U.S. economy, CEO Tim Cook said. But it’s also an effort by the technology giant to diversify its supply chains. Broadcom shares rose 1.2% on the news, but Apple dropped 1.5%.
- PRO Some stocks are on their way to a “golden cross” — when their 50-day moving average surpasses above the 200-day moving average. Investors see it as a sign that those stocks can rise further. CNBC found seven stocks displaying this bullish indicator.
The bottom line
The only story to be made of yesterday’s market moves is that, well, there wasn’t one. In other words, as I argued yesterday, markets are still in reactive mode, not a sustained rally.
Indeed, all three major indexes fell on Tuesday. The S&P 500 fell 1.12%, the Dow Jones Industrial Average slid 0.69% and the Nasdaq Composite tumbled 1.26%.
Investors were probably spooked by the lack of updates on the debt ceiling from Washington, despite U.S. President Joe Biden and House Speaker Kevin McCarthy describing their Monday meeting as “productive.”
And even if a deal were reached, analysts warn there’s more pain to come. With reserves in the U.S. Treasury’s account dwindling, the department will have to issue a lot of debt to get its account back to healthy levels, said Bill Merz, head of capital markets research at U.S. Bank Wealth Management. “The impact of that is likely to remove liquidity from the broader capital markets,” continued Mertz. That’s to say, stock prices might still drop after a deal is reached.
Nonetheless, there were pockets of good news amid the broader market slump yesterday.
Stocks of vaccine manufacturers jumped amid news of a fresh Covid-19 wave in China. BioNTech popped 8.2%, Pfizer added 2.3% and Moderna leaped 8.7%. Investors, however, should note this movement isn’t driven by any intrinsic change within the companies, but by external factors — and transient ones, at that. Covid waves come and go; vaccines stock prices will rise and fall in response.
PacWest surged 7.7% — and a further 4% in extended trading — after the U.S. regional bank announced Monday it would sell its real estate loans, which would improve its balance sheet. PacWest helped buoy other regional banks, such as KeyCorp, Comerica and Zions Bancorp, giving investors hope that the sector’s troubles will blow over soon.
But even concerns over regional banks are overshadowed by the unresolved debt ceiling. Markets can’t move until this sword of Damocles is gone — and, even then, there might be more problems to contend with.
Subscribe here to get this report sent directly to your inbox each morning before markets open.
